| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.27 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |